Orion Pharma Limited

DSE:ORIONPHARM Stock Report

Market Cap: ৳8.5b

Orion Pharma Past Earnings Performance

Past criteria checks 1/6

Orion Pharma's earnings have been declining at an average annual rate of -12.2%, while the Pharmaceuticals industry saw earnings growing at 9% annually. Revenues have been growing at an average rate of 10.8% per year. Orion Pharma's return on equity is 1%, and it has net margins of 2.3%.

Key information

-12.2%

Earnings growth rate

-12.2%

EPS growth rate

Pharmaceuticals Industry Growth11.0%
Revenue growth rate10.8%
Return on equity1.0%
Net Margin2.3%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Orion Pharma makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

DSE:ORIONPHARM Revenue, expenses and earnings (BDT Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 248,6581971,3040
30 Jun 2410,6213181,3440
31 Mar 2411,4964551,5040
31 Dec 2311,7594801,4820
30 Sep 2313,6226481,3690
30 Jun 2313,9276411,2820
31 Mar 2316,7937001,3150
31 Dec 2215,6338211,3570
30 Sep 2212,3899451,3100
30 Jun 229,6628461,2940
31 Mar 226,1509611,2290
31 Dec 217,4519381,1700
30 Sep 219,0918181,1630
30 Jun 2110,8339391,1380
31 Mar 2110,1937181,1380
31 Dec 209,2086391,0660
30 Sep 208,3505831,0370
30 Jun 207,6486661,0260
31 Mar 207,2108231,0210
31 Dec 196,9889019860
30 Sep 197,3529289780
30 Jun 198,7058829570
31 Mar 199,4858591,0150
31 Dec 1810,8027989660
30 Sep 1811,1457728790
30 Jun 1810,4238028550
31 Mar 1810,3277347350
31 Dec 1710,0857058310
30 Sep 179,7737797580
30 Jun 179,5347947760
31 Mar 179,6851,0447650
31 Dec 169,5699886870
30 Sep 169,7229854430
30 Jun 169,8678826580
30 Sep 1510,4177781,4910
30 Jun 1510,5907871,1150
31 Mar 1510,9389448690
31 Dec 1410,7079946860

Quality Earnings: ORIONPHARM has high quality earnings.

Growing Profit Margin: ORIONPHARM's current net profit margins (2.3%) are lower than last year (4.8%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: ORIONPHARM's earnings have declined by 12.2% per year over the past 5 years.

Accelerating Growth: ORIONPHARM's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: ORIONPHARM had negative earnings growth (-69.6%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (1.7%).

Return on Equity

High ROE: ORIONPHARM's Return on Equity (1%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/22 19:55
End of Day Share Price 2025/01/22 00:00
Earnings2024/09/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Orion Pharma Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution